High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia
Clinical trial NCT01459029 · UNKNOWN
Trial details
- NCT number
- NCT01459029
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.